Viewing StudyNCT00445458



Ignite Creation Date: 2024-05-05 @ 5:22 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00445458
Status: COMPLETED
Last Update Posted: 2018-07-26
First Post: 2007-03-08

Brief Title: A Phase 12 Study of HKI-272 Neratinib in Combination With Paclitaxel Taxol in Subjects With Solid Tumors and Breast Cancer
Sponsor: Puma Biotechnology Inc
Organization: Puma Biotechnology Inc

Conditions & Keywords Data

Conditions:
Name
Breast Neoplasms
Advanced Breast Cancer
Advanced Malignant Solid Tumors
Keywords:
Name View
cancer View
HKI-272 View
neratinib View
paclitaxel View
Taxol View
breast cancer View
Nerlynx View